Company
Headquarters: Tainan City, Taiwan
TW$4.12 Billion
TWD as of Jan. 1, 2024
US$134.3 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Syngen Biotech Co., Ltd. operates as a biotech company in Taiwan. The company manufactures and sells active pharmaceutical ingredients, including Mupirocin, an antibiotic against gram-positive bacteria that is used for the topical treatment of superficial infections, such as impetigo and infections, as well as to control infected eczema, wounds, and burns; and nutraceutical ingredients comprising probiotics, medicinal fungi, and entomogenous fungi. It also offers biology fermentation, biology agriculture and aquaculture, and functional food products. The company was founded in 1999 and is based in Tainan City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Syngen Biotech Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 8279 wb_incandescent